Effectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003-2004.
Identifieur interne : 000920 ( Main/Exploration ); précédent : 000919; suivant : 000921Effectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003-2004.
Auteurs : A. Banerji ; I. Tyler ; M S Finkelstein ; E. Gournis ; M F Pritchard ; F. Kolbe ; R. ShahinSource :
- Canada communicable disease report = Releve des maladies transmissibles au Canada [ 1188-4169 ] ; 2004.
Descripteurs français
- KwdFr :
- Analyse coût-bénéfice, Canada, Grippe humaine (), Grippe humaine (épidémiologie), Humains, Institutionnalisation, Maisons de repos, Recherche sur les services de santé, Résultat thérapeutique, Soins de longue durée, Vaccins antigrippaux (immunologie), Vaccins antigrippaux (usage thérapeutique), Vaccins inactivés (immunologie), Vaccins inactivés (usage thérapeutique).
- MESH :
- immunologie : Vaccins antigrippaux, Vaccins inactivés.
- usage thérapeutique : Vaccins antigrippaux, Vaccins inactivés.
- épidémiologie : Grippe humaine.
- Analyse coût-bénéfice, Canada, Grippe humaine, Humains, Institutionnalisation, Maisons de repos, Recherche sur les services de santé, Résultat thérapeutique, Soins de longue durée.
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- Canada, Cost-Benefit Analysis, Health Services Research, Humans, Influenza Vaccines (immunology), Influenza Vaccines (therapeutic use), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Institutionalization, Long-Term Care, Nursing Homes, Treatment Outcome, Vaccines, Inactivated (immunology), Vaccines, Inactivated (therapeutic use).
- MESH :
- chemical , immunology : Influenza Vaccines, Vaccines, Inactivated.
- chemical , therapeutic use : Influenza Vaccines, Vaccines, Inactivated.
- geographic : Canada.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- Cost-Benefit Analysis, Health Services Research, Humans, Institutionalization, Long-Term Care, Nursing Homes, Treatment Outcome.
PubMed: 15239482
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003-2004.</title><author><name sortKey="Banerji, A" sort="Banerji, A" uniqKey="Banerji A" first="A" last="Banerji">A. Banerji</name><affiliation><nlm:affiliation>Communicable Diseases Control, Toronto Public Health.</nlm:affiliation><wicri:noCountry code="subField">Toronto Public Health</wicri:noCountry></affiliation></author><author><name sortKey="Tyler, I" sort="Tyler, I" uniqKey="Tyler I" first="I" last="Tyler">I. Tyler</name></author><author><name sortKey="Finkelstein, M S" sort="Finkelstein, M S" uniqKey="Finkelstein M" first="M S" last="Finkelstein">M S Finkelstein</name></author><author><name sortKey="Gournis, E" sort="Gournis, E" uniqKey="Gournis E" first="E" last="Gournis">E. Gournis</name></author><author><name sortKey="Pritchard, M F" sort="Pritchard, M F" uniqKey="Pritchard M" first="M F" last="Pritchard">M F Pritchard</name></author><author><name sortKey="Kolbe, F" sort="Kolbe, F" uniqKey="Kolbe F" first="F" last="Kolbe">F. Kolbe</name></author><author><name sortKey="Shahin, R" sort="Shahin, R" uniqKey="Shahin R" first="R" last="Shahin">R. Shahin</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15239482</idno><idno type="pmid">15239482</idno><idno type="wicri:Area/Main/Corpus">000986</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000986</idno><idno type="wicri:Area/Main/Curation">000986</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000986</idno><idno type="wicri:Area/Main/Exploration">000986</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003-2004.</title><author><name sortKey="Banerji, A" sort="Banerji, A" uniqKey="Banerji A" first="A" last="Banerji">A. Banerji</name><affiliation><nlm:affiliation>Communicable Diseases Control, Toronto Public Health.</nlm:affiliation><wicri:noCountry code="subField">Toronto Public Health</wicri:noCountry></affiliation></author><author><name sortKey="Tyler, I" sort="Tyler, I" uniqKey="Tyler I" first="I" last="Tyler">I. Tyler</name></author><author><name sortKey="Finkelstein, M S" sort="Finkelstein, M S" uniqKey="Finkelstein M" first="M S" last="Finkelstein">M S Finkelstein</name></author><author><name sortKey="Gournis, E" sort="Gournis, E" uniqKey="Gournis E" first="E" last="Gournis">E. Gournis</name></author><author><name sortKey="Pritchard, M F" sort="Pritchard, M F" uniqKey="Pritchard M" first="M F" last="Pritchard">M F Pritchard</name></author><author><name sortKey="Kolbe, F" sort="Kolbe, F" uniqKey="Kolbe F" first="F" last="Kolbe">F. Kolbe</name></author><author><name sortKey="Shahin, R" sort="Shahin, R" uniqKey="Shahin R" first="R" last="Shahin">R. Shahin</name></author></analytic><series><title level="j">Canada communicable disease report = Releve des maladies transmissibles au Canada</title><idno type="ISSN">1188-4169</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Canada</term><term>Cost-Benefit Analysis</term><term>Health Services Research</term><term>Humans</term><term>Influenza Vaccines (immunology)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Institutionalization</term><term>Long-Term Care</term><term>Nursing Homes</term><term>Treatment Outcome</term><term>Vaccines, Inactivated (immunology)</term><term>Vaccines, Inactivated (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Analyse coût-bénéfice</term><term>Canada</term><term>Grippe humaine ()</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Institutionnalisation</term><term>Maisons de repos</term><term>Recherche sur les services de santé</term><term>Résultat thérapeutique</term><term>Soins de longue durée</term><term>Vaccins antigrippaux (immunologie)</term><term>Vaccins antigrippaux (usage thérapeutique)</term><term>Vaccins inactivés (immunologie)</term><term>Vaccins inactivés (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term><term>Vaccines, Inactivated</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term><term>Vaccines, Inactivated</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins inactivés</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins inactivés</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cost-Benefit Analysis</term><term>Health Services Research</term><term>Humans</term><term>Institutionalization</term><term>Long-Term Care</term><term>Nursing Homes</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Analyse coût-bénéfice</term><term>Canada</term><term>Grippe humaine</term><term>Humains</term><term>Institutionnalisation</term><term>Maisons de repos</term><term>Recherche sur les services de santé</term><term>Résultat thérapeutique</term><term>Soins de longue durée</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15239482</PMID><DateCompleted><Year>2004</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2005</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1188-4169</ISSN><JournalIssue CitedMedium="Print"><Volume>30</Volume><Issue>12</Issue><PubDate><Year>2004</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Canada communicable disease report = Releve des maladies transmissibles au Canada</Title><ISOAbbreviation>Can. Commun. Dis. Rep.</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003-2004.</ArticleTitle><Pagination><MedlinePgn>109-16</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banerji</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Communicable Diseases Control, Toronto Public Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyler</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Finkelstein</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Gournis</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Pritchard</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Kolbe</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Shahin</LastName><ForeName>R</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><Language>fre</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can Commun Dis Rep</MedlineTA><NlmUniqueID>9303729</NlmUniqueID><ISSNLinking>1188-4169</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006302" MajorTopicYN="N">Health Services Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007326" MajorTopicYN="N">Institutionalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009735" MajorTopicYN="Y">Nursing Homes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>7</Month><Day>9</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>8</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>7</Month><Day>9</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15239482</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Banerji, A" sort="Banerji, A" uniqKey="Banerji A" first="A" last="Banerji">A. Banerji</name><name sortKey="Finkelstein, M S" sort="Finkelstein, M S" uniqKey="Finkelstein M" first="M S" last="Finkelstein">M S Finkelstein</name><name sortKey="Gournis, E" sort="Gournis, E" uniqKey="Gournis E" first="E" last="Gournis">E. Gournis</name><name sortKey="Kolbe, F" sort="Kolbe, F" uniqKey="Kolbe F" first="F" last="Kolbe">F. Kolbe</name><name sortKey="Pritchard, M F" sort="Pritchard, M F" uniqKey="Pritchard M" first="M F" last="Pritchard">M F Pritchard</name><name sortKey="Shahin, R" sort="Shahin, R" uniqKey="Shahin R" first="R" last="Shahin">R. Shahin</name><name sortKey="Tyler, I" sort="Tyler, I" uniqKey="Tyler I" first="I" last="Tyler">I. Tyler</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000920 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000920 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:15239482
|texte= Effectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003-2004.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15239482" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |